Pharmacy Grand Rounds
PIC-ing Up on Post-Intensive Care Syndrome: Current Care Gaps and Strategies for Management

ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P

• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)

Until further notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

Post-intensive care syndrome (PICS) describes the impairment of cognition, psychological health, and/or physicial function that remain in the wake of critical illness. Current reports indicate up to 40% of ICU survivors experience some degree of PICS symptoms, often manifesting in the form of muscle weakness or problems with balance, issues with thinking and memory, severe anxiety, depression, or nightmares, which persist beyond discharge from the acute care setting. Unfortunately, post-ICU impairments are often undiagnosed and inadequately treated. This presentation will review the evidence regarding management of ICU survivors and describe the experience of creating a multidisciplinary clinic practice to address this care gap.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Describe the incidence and clinical manifestation of PICS
2. Review literature examining the long term implications of critical illness.
3. Discuss current strategies to address care gaps related to PICS symptom recognition and management

Session Announcement

Session Slides

FACULTY INFORMATION

Shannon L. Piche, PharmD, BCPS
Clinical Pharmacist - Critical Care
Mayo Clinic Hospital - Rochester, MN

Shannon received a Doctor of Pharmacy degree from the University of Iowa College of Pharmacy and completed PGY1 and PGY2 Critical Care pharmacy residencies at Mayo Clinic Hospital - Rochester.  She is a current critical care pharmacist at Mayo Clinic, with a clinical practice in the immunocompromised ICU.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Shannon L. Piche, PharmD, BCPS
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will not be discussed during this presentation.

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS